search
Back to results

Sedation Management in Pediatric Patients Supported on Mechanical Ventilation

Primary Purpose

Respiratory Failure

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Nurse Implemented Goal-Directed Comfort Algorithm
Sponsored by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Failure focused on measuring Sedation, Mechanical ventilation, Critical illness, Analgesic, Opioid Withdrawal, Benzodiazepine Withdrawal, Nurse

Eligibility Criteria

2 Weeks - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Intubated and mechanically ventilated Pulmonary disease Exclusion Criteria: Less than or equal to 2 weeks of age or 42 weeks corrected gestational age Greater than 18 years of age Intubated and mechanically ventilated for immediate post-operative care and stabilization Cyanotic heart disease with unrepaired or palliated right to left intracardiac shunt Critical airway (e.g. post laryngotracheal reconstruction) Ventilator dependent (including noninvasive) on PICU admission (chronic assisted ventilation) Neuromuscular respiratory failure Spinal cord injury above the lumbar region Managed by patient controlled analgesia (PCA)or epidural catheter Known allergy to any of the study medications (Morphine,Methadone, Midazolam, Lorazepam) Family/Medical team have decided not to provide full support(patient treatment considered futile) Previously enrolled into the current study or enrolled in any other sedation clinical trial concurrently or within the last 30 days

Sites / Locations

  • Children's National Medical Center
  • Children's Hospital Boston
  • Children's Hospital of Wisconsin

Outcomes

Primary Outcome Measures

Duration of Mechanical Ventilation

Secondary Outcome Measures

Time to Recovery of Lung Injury
Duration of Weaning from Mechanical Ventilation
Occurrence of Adverse Events
Total Exposure to Comfort Medications
Occurrence of Iatrogenic Abstinence Syndrome
PICU Length of Stay
Barriers to Successful Implementation of the Intervention
PICU costs

Full Information

First Posted
August 31, 2005
Last Updated
October 5, 2015
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborators
Gustavus and Louise Pfeiffer Research Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00142766
Brief Title
Sedation Management in Pediatric Patients Supported on Mechanical Ventilation
Official Title
Sedation Management in Pediatric Patients Supported on Mechanical Ventilation
Study Type
Interventional

2. Study Status

Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
February 2004 (undefined)
Primary Completion Date
July 2006 (Actual)
Study Completion Date
March 2007 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborators
Gustavus and Louise Pfeiffer Research Foundation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this two-year project is to pilot test an intervention to change sedation management in pediatric patients supported on mechanical ventilation for acute respiratory failure in the pediatric intensive care unit (PICU). While ensuring patient comfort is an integral part of pediatric critical care, analgesic and sedative use in this patient population is associated with injury; specifically, comfort medications may depress spontaneous ventilation and prolong the duration of mechanical ventilation. Additionally, drug tolerance develops over time and may precipitate iatrogenic abstinence syndrome (chemical withdrawal) when the patient no longer requires sedation. Alternatively, suboptimal comfort management contributes to the patient not breathing synchronously with the ventilator and/or self-removal of breathing tubes. Our group has developed and validated a nurse-implemented sedation algorithm (set of specific instructions) to guide titration of comfort medications that may optimize patient comfort and reduce the risk of under-medication, but this algorithm needs to be evaluated further. We hypothesize that pediatric patients managed per sedation protocol will experience fewer days of mechanical ventilation than patients receiving usual care. This research has the potential of revolutionizing sedation practices that are driven by and synchronized to patient needs.
Detailed Description
We propose a two-year project to pilot test and evaluate an intervention to change sedation management in pediatric patients supported on mechanical ventilation for acute respiratory failure in the PICU. Rather than seeking an elusive ideal drug, this unique nurse-led pilot study focuses on optimizing clinical decision making by: (a) multidisciplinary team education and consensus building; (b) multidisciplinary team identification of the patient's trajectory of illness and daily prescribing of a sedation goal; (c) a nurse-implemented sedation algorithm to guide titration of comfort medications; and(d)team feedback on clinical performance. This intervention models the most recent sedation clinical practice guideline published by the Society of Critical Care Medicine and addresses the only potentially manipulable factor influencing extubation failures rates in the Pediatric Intensive Care Unit. The coordinating center, Children's Hospital Boston, developed, tested and currently uses the sedation algorithm as a standard of care. We will pilot the intervention in two separate previously selected PICUs that are matched on size and organization, academic affiliation and volume of patients supported on mechanical ventilation. One PICU will be randomized to receive early intervention while the other will first serve as a control, then will receive a delayed intervention. The study design is a randomized controlled trial with delayed intervention in the control hospital. Because the intervention is an educational and organizational change directed at all PICU clinicians, the unit of randomization and analysis is the PICU. During the start-up phase, case report forms will be developed and a consensus meeting with all nurse and physician co-investigators will be conducted. The purpose of this consensus meeting will be to review the Children's Hospital Boston experience with the sedation algorithm and reach agreement on its application in the two PICUs. System nuances may impact protocol implementation and will require group discussion and multidisciplinary problem solving. Study design includes baseline assessment of the organizational structure and comfort practices in both units. The PICU randomized to early intervention will then undergo training followed by implementation, a one-month respite, and post-data collection to evaluate the sustainability of the practice change. The PICU randomized to delayed intervention will start with pre-data collection, then undergo training followed by implementation. This design allows multiple comparisons; specifically, baseline to intervention/control, pre and post comparisons in both units, and sustainability in one unit. Training will be multifaceted and will include all clinicians (physicians, nurses, clinical pharmacists and physicians-in-training) involved in the sedation management of intubated mechanically-ventilated patients. A multidisciplinary, cooperative approach is necessary to assure compliance and successful implementation of protocols. Training material will include discipline-specific lectures, informal discussions, video on sedation and opioid withdrawal scoring, bedside booklets, and physician order sheets. The research team will develop the supporting materials. Physician training will focus on sedation and opioid withdrawal scoring, identifying the patient's trajectory of illness, collaborating with nursing in prescribing the daily sedation goal, and completion of the standardized order template. Nursing content will likewise focus on sedation and opioid withdrawal scoring, trajectory analysis and collaboration, but also will include practical support on the daily "wake-up" test and titration of sedatives. Prior to the intervention phase, all physicians, physician-in-training, unit-based clinical pharmacist, charge nurses and full-time nursing staff will be required to document their understanding of the intervention by completion of a discipline-specific scenario-based self-assessment evaluation. Respiratory therapists will also require refresher instruction on extubation readiness testing and general information about sedation assessment and sedation algorithm. During the implementation phase, daily multidisciplinary rounds will include identification of the patient's trajectory of illness and daily prescription of (a) sedation goal and (b) sedation parameters. Nurses will titrate the comfort medications as prescribed and perform a daily "wake up" test in patients during their stable phase who are not awake. During the implementation phase, a member of the research team will round separately on each patient to monitor for study compliance and offer staff support and re-training as necessary. This level of vigilance is necessary to identify aspects of the algorithm that are challenging to clinicians, and accurate reporting of protocol deviations requires an evaluation of the context of decision-making. This daily check will not continue in the early intervention arm when sustainability is evaluated. During the implementation phase, all sedation orders will be derived from standardized physician orders. This order template will serve two purposes: physician education and enhanced compliance with the algorithm

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Failure
Keywords
Sedation, Mechanical ventilation, Critical illness, Analgesic, Opioid Withdrawal, Benzodiazepine Withdrawal, Nurse

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
245 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Nurse Implemented Goal-Directed Comfort Algorithm
Intervention Description
See description
Primary Outcome Measure Information:
Title
Duration of Mechanical Ventilation
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Time to Recovery of Lung Injury
Time Frame
28 days
Title
Duration of Weaning from Mechanical Ventilation
Time Frame
28 days
Title
Occurrence of Adverse Events
Time Frame
28 days
Title
Total Exposure to Comfort Medications
Time Frame
28 days
Title
Occurrence of Iatrogenic Abstinence Syndrome
Time Frame
28 days
Title
PICU Length of Stay
Time Frame
28 days
Title
Barriers to Successful Implementation of the Intervention
Time Frame
28 days
Title
PICU costs
Time Frame
28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Weeks
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Intubated and mechanically ventilated Pulmonary disease Exclusion Criteria: Less than or equal to 2 weeks of age or 42 weeks corrected gestational age Greater than 18 years of age Intubated and mechanically ventilated for immediate post-operative care and stabilization Cyanotic heart disease with unrepaired or palliated right to left intracardiac shunt Critical airway (e.g. post laryngotracheal reconstruction) Ventilator dependent (including noninvasive) on PICU admission (chronic assisted ventilation) Neuromuscular respiratory failure Spinal cord injury above the lumbar region Managed by patient controlled analgesia (PCA)or epidural catheter Known allergy to any of the study medications (Morphine,Methadone, Midazolam, Lorazepam) Family/Medical team have decided not to provide full support(patient treatment considered futile) Previously enrolled into the current study or enrolled in any other sedation clinical trial concurrently or within the last 30 days
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martha AQ Curley, RN PhD FAAN
Organizational Affiliation
Boston Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's National Medical Center
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20010
Country
United States
Facility Name
Children's Hospital Boston
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
Facility Name
Children's Hospital of Wisconsin
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53201
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
30558653
Citation
Curley MAQ, Gedeit RG, Dodson BL, Amling JK, Soetenga DJ, Corriveau CO, Asario LA, Wypij D; RESTORE Investigative Team. Methods in the design and implementation of the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial. Trials. 2018 Dec 17;19(1):687. doi: 10.1186/s13063-018-3075-8. Erratum In: Trials. 2019 Jan 7;20(1):17. Asaro, Lisa A [corrected to Asario, Lisa A].
Results Reference
derived

Learn more about this trial

Sedation Management in Pediatric Patients Supported on Mechanical Ventilation

We'll reach out to this number within 24 hrs